Point of Care molecular diagnostics is one of the fastest growing markets with recent and expected CAGRs at the 10% level and above.
The innovative technology behind the PCR|ONE system offers a unique combination of the best features of the few competitors on the Point of Care PCR market. The PCR|ONE with the unparalleled combination of speed and breath of the panels may be used in a diverse set of clinical settings, from first-contact identification of the source of infections to specialized care. The combination of comprehensive answers with rapid turnaround time and minimum hands-on time prompted an enthusiastic response of the diagnostic laboratories and clinics.
Curiosity Diagnostics has completed the second round of investment devoted to preparation of the system for external validation and for industrialization. We are now beginning the subscriptions for the third round of investment aimed at funding the industrialization and introduction to the market.
Should you be interested in the investment opportunity we invite you to contact the members of the executive board.